Inventor · disambiguated record
John Pluenneke
Also filed as: ARMITAGE RICHARD J · PLUENNEKE JOHN D
3 granted patents·15 pending applications·198 citations·filing 2001–2018
78Inventor score
Files withIMMUNEX CORP11
Top patents by PatentIndex Score
18 records- 0196US7186809B2Methods and compositions relating to anti-interleukin-4 receptor antibodiesIMMUNEX CORP·Filed 2002·Granted Mar 6, 2007·148 cites·17 claims
- 0292US7465450B2Methods and compositions relating to anti-interleukin-4 receptor antibodiesIMMUNEX CORP·Filed 2006·Granted Dec 16, 2008·38 cites·11 claims
- 0380US7122183B2Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30LIMMUNEX CORP·Filed 2003·Granted Oct 17, 2006·12 cites·23 claims
- 0466US2019023798A1Use of interleukin-4 antagonists and compositions thereofIMMUNEX CORP·Filed 2018·Application pending·0 cites
- 0566US2010071079A1Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30lIMMUNEX CORP·Filed 2009·Application pending·0 cites
- 0664US2018171016A1Use of interleukin-4 antagonists and compositions thereofIMMUNEX CORP·Filed 2018·Application pending·0 cites
- 0764US2009104662A1Use of interleukin-4 antagonists and compositions thereofIMMUNEX CORP·Filed 2008·Application pending·0 cites
- 0861US2017137526A1Use of interleukin-4 antagonists and compositions thereofIMMUNEX CORP·Filed 2017·Application pending·0 cites
- 0961US2004220103A1Soluble tumor necrosis factor receptor treatment of medical disordersIMMUNEX CORP·Filed 2004·Application pending·0 cites
- 1060US2008213259A1Methods for Treating Autoimmune and Chronic Inflammatory Conditions Using Antagonists of CD30 or CD30LIMMUNEX CORP·Filed 2007·Application pending·0 cites
- 1150US2008166336A1CD137 agonists to treat patients with IgE-mediated conditionsIMMUNEX CORP·Filed 2007·Application pending·0 cites
- 1248US2004147428A1Methods of treatment using an inhibitor of epidermal growth factor receptorFiled 2003·Application pending·0 cites
- 1345US2003148955A1Soluble tumor necrosis factor receptor treatment of medical disordersFiled 2002·Application pending·0 cites
- 1445US2002076409A1Method for treating cancerFiled 2001·Application pending·0 cites
- 1544US2003223989A1CD137 agonists to treat patients with IgE-mediated conditionsFiled 2003·Application pending·0 cites
- 1640US2003170244A1Inhibition of Fas signalingFiled 2002·Application pending·0 cites
- 1739US2002002132A1Use of interleukin-4 antagonists and compositions thereofFiled 2001·Application pending·0 cites
- 1834US2001021380A1Soluble tumor necrosis factor receptor treatment of medical disordersFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Pluenneke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →